clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16 Search Results


99
ATCC clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16
Clarithromycin Against E Coli Atcc 25922 In Vitro Graphical Abstract Compound 16, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16/product/ATCC
Average 99 stars, based on 1 article reviews
clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC klebsiella aerogenes tindall et al
Klebsiella Aerogenes Tindall Et Al, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/klebsiella aerogenes tindall et al/product/ATCC
Average 99 stars, based on 1 article reviews
klebsiella aerogenes tindall et al - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC bacillus cereus frankland and frankland
Bacillus Cereus Frankland And Frankland, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bacillus cereus frankland and frankland/product/ATCC
Average 99 stars, based on 1 article reviews
bacillus cereus frankland and frankland - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

98
ATCC article f1 fig graphic
Article F1 Fig Graphic, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/article f1 fig graphic/product/ATCC
Average 98 stars, based on 1 article reviews
article f1 fig graphic - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

96
ATCC caption a7 antimicrobial activity
Caption A7 Antimicrobial Activity, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 antimicrobial activity/product/ATCC
Average 96 stars, based on 1 article reviews
caption a7 antimicrobial activity - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

91
ATCC caption a7 rapid bactericidal action against mrsa
Caption A7 Rapid Bactericidal Action Against Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 rapid bactericidal action against mrsa/product/ATCC
Average 91 stars, based on 1 article reviews
caption a7 rapid bactericidal action against mrsa - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

94
ATCC gentamicin
Gentamicin, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gentamicin/product/ATCC
Average 94 stars, based on 1 article reviews
gentamicin - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
ATCC rifampin
Rifampin, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rifampin/product/ATCC
Average 93 stars, based on 1 article reviews
rifampin - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
DeLano Scientific pymol molecular graphic suite
Pymol Molecular Graphic Suite, supplied by DeLano Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pymol molecular graphic suite/product/DeLano Scientific
Average 90 stars, based on 1 article reviews
pymol molecular graphic suite - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
ATCC ciprofloxacin
MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry
Ciprofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ciprofloxacin/product/ATCC
Average 92 stars, based on 1 article reviews
ciprofloxacin - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

99
ATCC p aeruginosa atcc 27853 imipenem
(Left panels) Dot plots of FSC peak height (shown as FSC-H), indicative of size, and FL2 peak height (shown as FL2-H), indicative of double-stranded nucleic acid content, for the untreated control organisms E. coli ATCC 25922 and P. aeruginosa <t>ATCC</t> <t>27853</t> in the logarithmic-growth phase. The gates used are also shown (R1 for E. coli and R2 for P. aeruginosa). (Right panels) Histograms for bacterial size (FSC-H), with three intervals, representing 2 SDs (97.4th percentile), 2 to 4 SDs (97.4th to 99.2th percentile), and >4 SDs (>99.2th percentile) of the control size distribution. These intervals were used for comparisons between controls and antibiotic-exposed organisms.
P Aeruginosa Atcc 27853 Imipenem, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p aeruginosa atcc 27853 imipenem/product/ATCC
Average 99 stars, based on 1 article reviews
p aeruginosa atcc 27853 imipenem - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC caption a7 organism antibiotic mic
(Left panels) Dot plots of FSC peak height (shown as FSC-H), indicative of size, and FL2 peak height (shown as FL2-H), indicative of double-stranded nucleic acid content, for the untreated control organisms E. coli ATCC 25922 and P. aeruginosa <t>ATCC</t> <t>27853</t> in the logarithmic-growth phase. The gates used are also shown (R1 for E. coli and R2 for P. aeruginosa). (Right panels) Histograms for bacterial size (FSC-H), with three intervals, representing 2 SDs (97.4th percentile), 2 to 4 SDs (97.4th to 99.2th percentile), and >4 SDs (>99.2th percentile) of the control size distribution. These intervals were used for comparisons between controls and antibiotic-exposed organisms.
Caption A7 Organism Antibiotic Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 organism antibiotic mic/product/ATCC
Average 99 stars, based on 1 article reviews
caption a7 organism antibiotic mic - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques:

(A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting. As shown, no PAE was seen after ceftriaxone exposure, but ciprofloxacin induced a PAE of 1.9 h. The organisms were stained with propidium iodide and examined by fluorescence microscopy. (B through D) Photomicrographs of untreated control organisms (B), ceftriaxone-exposed organisms 35 min after drug removal (C), and ciprofloxacin-exposed organisms 270 min after drug removal (D). Both antibiotics induced filamentation, but this morphological form persisted past the classically defined PAE in organisms exposed to ciprofloxacin. Magnification, ×880.

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting. As shown, no PAE was seen after ceftriaxone exposure, but ciprofloxacin induced a PAE of 1.9 h. The organisms were stained with propidium iodide and examined by fluorescence microscopy. (B through D) Photomicrographs of untreated control organisms (B), ceftriaxone-exposed organisms 35 min after drug removal (C), and ciprofloxacin-exposed organisms 270 min after drug removal (D). Both antibiotics induced filamentation, but this morphological form persisted past the classically defined PAE in organisms exposed to ciprofloxacin. Magnification, ×880.

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques: Concentration Assay, Staining, Fluorescence, Microscopy

Histograms showing a comparison of the size distributions (FSC-H; left panels) and nucleic acid contents (FL2-H; middle panels) of E. coli during the PAE after exposure to ciprofloxacin at a concentration equivalent to the MIC and at a concentration equivalent to twice the MIC at 270 min after drug removal. Dotted-and-dashed lines, control organisms; solid lines, bacteria previously exposed to ciprofloxacin. Graphs (right panels) show progressive changes in size compared to sizes of controls. The sizes of antibiotic-treated organisms were compared to three control size intervals described in the text and shown in Fig. ​Fig.2.2. Open circles, bacteria within 2 SDs of control size; solid squares, bacteria within 2 to 4 SDs; open squares, organisms >4 SDs from the control distribution.

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: Histograms showing a comparison of the size distributions (FSC-H; left panels) and nucleic acid contents (FL2-H; middle panels) of E. coli during the PAE after exposure to ciprofloxacin at a concentration equivalent to the MIC and at a concentration equivalent to twice the MIC at 270 min after drug removal. Dotted-and-dashed lines, control organisms; solid lines, bacteria previously exposed to ciprofloxacin. Graphs (right panels) show progressive changes in size compared to sizes of controls. The sizes of antibiotic-treated organisms were compared to three control size intervals described in the text and shown in Fig. ​Fig.2.2. Open circles, bacteria within 2 SDs of control size; solid squares, bacteria within 2 to 4 SDs; open squares, organisms >4 SDs from the control distribution.

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques: Concentration Assay

Histograms showing the size distributions (FSC-H; left panels) and nucleic acid contents (FL2-H; middle panels) of P. aeruginosa during the PAE after exposure to imipenem at a concentration equivalent to twice the MIC and to ciprofloxacin at a concentration equivalent to the MIC at 180 and 70 min after drug removal, respectively. Dotted-and-dashed lines, control organisms; solid lines, antibiotic-exposed organisms. The graphs (right panels) show progressive changes in size compared to sizes of controls. The sizes of antibiotic-treated organisms were compared to three control size intervals described in text and shown in Fig. ​Fig.2.2. Open circles, bacteria within 2 SDs of control size; solid squares, bacteria within 2 to 4 SDs; open squares, organisms >4 SDs from the control distribution.

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: Histograms showing the size distributions (FSC-H; left panels) and nucleic acid contents (FL2-H; middle panels) of P. aeruginosa during the PAE after exposure to imipenem at a concentration equivalent to twice the MIC and to ciprofloxacin at a concentration equivalent to the MIC at 180 and 70 min after drug removal, respectively. Dotted-and-dashed lines, control organisms; solid lines, antibiotic-exposed organisms. The graphs (right panels) show progressive changes in size compared to sizes of controls. The sizes of antibiotic-treated organisms were compared to three control size intervals described in text and shown in Fig. ​Fig.2.2. Open circles, bacteria within 2 SDs of control size; solid squares, bacteria within 2 to 4 SDs; open squares, organisms >4 SDs from the control distribution.

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques: Concentration Assay

(Left panels) Dot plots of FSC peak height (shown as FSC-H), indicative of size, and FL2 peak height (shown as FL2-H), indicative of double-stranded nucleic acid content, for the untreated control organisms E. coli ATCC 25922 and P. aeruginosa ATCC 27853 in the logarithmic-growth phase. The gates used are also shown (R1 for E. coli and R2 for P. aeruginosa). (Right panels) Histograms for bacterial size (FSC-H), with three intervals, representing 2 SDs (97.4th percentile), 2 to 4 SDs (97.4th to 99.2th percentile), and >4 SDs (>99.2th percentile) of the control size distribution. These intervals were used for comparisons between controls and antibiotic-exposed organisms.

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: (Left panels) Dot plots of FSC peak height (shown as FSC-H), indicative of size, and FL2 peak height (shown as FL2-H), indicative of double-stranded nucleic acid content, for the untreated control organisms E. coli ATCC 25922 and P. aeruginosa ATCC 27853 in the logarithmic-growth phase. The gates used are also shown (R1 for E. coli and R2 for P. aeruginosa). (Right panels) Histograms for bacterial size (FSC-H), with three intervals, representing 2 SDs (97.4th percentile), 2 to 4 SDs (97.4th to 99.2th percentile), and >4 SDs (>99.2th percentile) of the control size distribution. These intervals were used for comparisons between controls and antibiotic-exposed organisms.

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques:

MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry

Journal:

Article Title: Characteristics and Dynamics of Bacterial Populations during Postantibiotic Effect Determined by Flow Cytometry

doi:

Figure Lengend Snippet: MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry

Article Snippet: Growth curves from typical PAE experiments with ceftriaxone and ciprofloxacin (each at a concentration equivalent to twice the MIC) against E. coli are shown in Fig. A. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Antibiotic MIC (μg/ml) Multiple of MIC PAE (h) E. coli ATCC 25922 Ampicillin 2.0 2 −0.3 4 −0.4 8 −0.3 Ceftriaxone 0.03 2 −0.3 4 −0.2 8 −0.5 Gentamicin 1.0 1 0.7 2 0.6 Ciprofloxacin 0.015 1 1.5 2 2.7 Rifampin 16 1 0.6 2 1.5 P. aeruginosa ATCC 27853 Imipenem 2.0 2 1.3 4 1.9 8 2.6 Ciprofloxacin 0.5 2 0.7 Open in a separate window MICs, multiples of MICs, and duration of PAEs for organism-antibiotic combinations studied by flow cytometry fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1 caption a7 (A) A typical PAE experiment for E. coli ATCC 25922 after exposure to ceftriaxone or ciprofloxacin (each at a concentration equivalent to twice the MIC), as determined by viability counting.

Techniques: